Researchers, physicians, families and affected patients view Duchenne muscular dystrophy (DMD) as a neuromuscular condition. Children are diagnosed during the first years of life because they have ...
Columnist Betty Vertin recognizes the admirable traits in those living with Duchenne muscular dystrophy — and their moms.
Activities of daily life, education, and employment were areas of difficulty in the transition to adulthood for patients with ...
ITF, IntraBio and Orchard are among the companies that have won FDA nods in the past year for Duchenne muscular dystrophy, ...
Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCstm), today announced it is joining the ...
University of Adelaide research into health and fertility has been funded in the latest round of the National Health and ...
Givinostat should be available to people with Duchenne muscular dystrophy through a type of compassionate use scheme.
Solid Biosciences reported recent positive data in developing their gene therapy candidate SGT-003. The phase 1/2 INSPIRE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback